Original Article
Copyright ©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Aug 28, 2012; 18(32): 4300-4307
Published online Aug 28, 2012. doi: 10.3748/wjg.v18.i32.4300
Results of National Colorectal Cancer Screening Program in Croatia (2007-2011)
Miroslava Katičić, Nataša Antoljak, Milan Kujundžić, Valerija Stamenić, Dunja Skoko Poljak, Danica Kramarić, Davor Štimac, Marija Strnad Pešikan, Mirko Šamija, Zdravko Ebling
Miroslava Katičić, Department of Gastroenterology, Merkur University Hospital, 10000 Zagreb, Croatia
Nataša Antoljak, Chronic Mass Disease Epidemiology Service, Croatian National Institute of Public Health and Zagreb University School of Medicine, Dr. Andrija Štampar School of Public Health, 10000 Zagreb, Croatia
Milan Kujundžić, Department of Gastroenterology, Dubrava University Hospital, 10000 Zagreb, Croatia
Valerija Stamenić, Dunja Skoko Poljak, Danica Kramarić, Ministry of Health and Social Welfare, 10000 Zagreb, Croatia
Davor Štimac, Department of Gastroenterology, Rijeka University Hospital Centre, 51000 Rijeka, Croatia
Marija Strnad Pešikan, Zagreb University School of Medicine, Dr. Andrija Štampar School of Public Health, 10000 Zagreb, Croatia
Mirko Šamija, Zagreb University School of Medicine, 10000 Zagreb, Croatia
Zdravko Ebling, Osijek Health Centre, 31000 Osijek, Croatia
Author contributions: Katičić M and Antoljak N designed the study, ensured the acquisition, analysis, and interpretation of data and wrote the first draft; Stamenić V, Strnad Pešikan M, Šamija M and Ebling Z designed a plan of Colorectal National Screening Program and critically revised this paper; Kujundžić M and Štimac D were involved in supervision and supportive activities during program implementation; Skoko Poljak D and Kramarić D assured funding, administration, technology and material support.
Correspondence to: Dr. Katičić Miroslava, Professor, Department of Gastroenterology, Merkur University Hospital, Zajčeva 19, 10000 Zagreb, Croatia. mkaticic@mef.hr
Telephone: +385-1-2308461 Fax: +385-1-3130250
Received: June 16, 2012
Revised: August 16, 2012
Accepted: August 18, 2012
Published online: August 28, 2012
Abstract

AIM: To study the epidemiologic indicators of uptake and characteristic colonoscopic findings in the Croatian National Colorectal Cancer Screening Program.

METHODS: Colorectal cancer (CRC) was the second leading cause of cancer mortality in men (n = 1063, 49.77/100  000), as well as women (n = 803, 34.89/100  000) in Croatia in 2009. The Croatian National CRC Screening Program was established by the Ministry of Health and Social Welfare, and its implementation started in September, 2007. The coordinators were recruited in each county institute of public health with an obligation to provide fecal occult blood testing (FOBT) to the participants, followed by colonoscopy in all positive cases. The FOBT was performed by hypersensitive guaiac-based Hemognost card test (Biognost, Zagreb). The test and short questionnaire were delivered to the home addresses of all citizens aged 50-74 years consecutively during a 3-year period. Each participant was required to complete the questionnaire and send it together with the stool specimen on three test cards back to the institute for further analysis. About 4% FOBT positive cases are expected in normal risk populations. A descriptive analysis was performed.

RESULTS: A total of 1  056  694 individuals (born between 1933-1945 and 1952-1957) were invited to screening by the end of September 2011. In total, 210  239 (19.9%) persons returned the envelope with a completed questionnaire, and 181 102 of them returned it with a correctly placed stool specimen on FOBT cards. Until now, 12  477 (6.9%), FOBT-positive patients have been found, which is at the upper limit of the expected values in European Guidelines for Quality Assurance in CRC Screening and Diagnosis [European Union (EU) Guidelines]. Colonoscopy was performed in 8541 cases (uptake 66%). Screening has identified CRC in 472 patients (5.5% of colonoscopied, 3.8% of FOBT-positive, and 0.26% of all screened individuals). This is also in the expected range according to EU Guidelines. Polyps were found and removed in 3329 (39% of colonoscopied) patients. The largest number of polyps were found in the left half of the colon: 64% (19%, 37% and 8% in the rectum, sigma, and descendens, respectively). The other 36% were detected in the proximal part (17% in the transverse colon and 19% in ceco-ascending colon). Small polyps in the rectum (5-10 mm in diameter), sigmoid and descending colon were histologically found to be tubular adenomas in 60% of cases, with a low degree of dysplasia, and 40% were classified as hyperplastic. Polyps of this size in the transverse or ceco-ascending colon in almost 20% had a histologically villous component, but still had a low degree of dysplasia. Polyps sized 10-20 mm in diameter were in 43% cases tubulovillous, and among them, 32% had areas with a high degree of dysplasia, especially those polyps in the ceco-ascending or transverse part. The characteristics of the Croatian CRC Screening National Program in the first 3 years were as follows: relatively low percentage of returned FOBT, higher number of FOBT-positive persons but still in the range for population-based programs, and higher number of pathologic findings (polyps and cancers).

CONCLUSION: These results suggest a need for intervention strategies that include organizational changes and educational activities to improve awareness of CRC screening usefulness and increase participation rates.

Keywords: Colorectal cancer screening; Fecal occult blood testing; Croatian National Colorectal Cancer Screening Program; Colonoscopy; Uptake